A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome

BACKGROUND: Accumulating evidence supports the view that an imbalance of gut bacteria contributes to IBS, and that increasing the mass of beneficial species may reduce the numbers of pathogenic bacteria and help alleviate symptoms. METHODS: In this double-blind trial 400 adult patients with moderate...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishaque, Shamsuddin M., Khosruzzaman, S. M., Ahmed, Dewan Saifuddin, Sah, Mukesh Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970461/
https://www.ncbi.nlm.nih.gov/pubmed/29801486
http://dx.doi.org/10.1186/s12876-018-0788-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970461/
https://www.ncbi.nlm.nih.gov/pubmed/29801486
http://dx.doi.org/10.1186/s12876-018-0788-9

Ejemplares similares